{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:30:22Z","timestamp":1787574622189,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"DOI":"10.1038\/s41429-026-00954-8","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:02:45Z","timestamp":1787569365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cLariocidin and ribosome-targeting lasso peptides as emerging antimicrobial agents against multidrug-resistant bacteria\u201d"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3487-1971","authenticated-orcid":false,"given":"Ahmed","family":"Mahdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Alam-ElDein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend H.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Abuelhaded","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzahraa","family":"Elhemiely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"El-zahraa R.Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Kamel","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H. A.","family":"Gadelmawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elkhawanky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Abdelkhalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H. I.","family":"Faraag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"954_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/epidemiologia6020021","volume":"6","author":"A Marino","year":"2025","unstructured":"Marino A, Maniaci A, Lentini M, Ronsivalle S, Nunnari G, Cocuzza S, et al. The Global Burden of Multidrug-Resistant Bacteria. Epidemiologia. 2025;6:21.","journal-title":"Epidemiologia"},{"key":"954_CR2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","volume":"25","author":"H Sati","year":"2025","unstructured":"Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, et al. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. 2025;25:1033\u201343.","journal-title":"Lancet Infect Dis"},{"key":"954_CR3","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1021\/acsinfecdis.4c00530","volume":"10","author":"LJV Piddock","year":"2024","unstructured":"Piddock LJV, Malpani R, Hennessy A. Challenges and Opportunities with Antibiotic Discovery and Exploratory Research. ACS Infect Dis. 2024;10:2445\u20137.","journal-title":"ACS Infect Dis"},{"key":"954_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/d41573-025-00059-1","volume":"24","author":"S Crunkhorn","year":"2025","unstructured":"Crunkhorn S. Identifying novel antibiotic targets. Nat Rev Drug Discov. 2025;24:334.","journal-title":"Nat Rev Drug Discov"},{"key":"954_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/biom14101263","volume":"14","author":"SJ Krawczyk","year":"2024","unstructured":"Krawczyk SJ, Le\u015bniczak-Staszak M, Gowin E, Szaflarski W. Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics. Biomolecules. 2024;14:1263.","journal-title":"Biomolecules"},{"key":"954_CR6","doi-asserted-by":"publisher","first-page":"102562","DOI":"10.1016\/j.mib.2024.102562","volume":"83","author":"MA Farha","year":"2025","unstructured":"Farha MA, Tu MM, Brown ED. Important challenges to finding new leads for new antibiotics. Curr Opin Microbiol. 2025;83:102562.","journal-title":"Curr Opin Microbiol"},{"key":"954_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","volume":"4","author":"JM Munita","year":"2016","unstructured":"Munita JM, Arias CA. Mechanisms of Antibiotic Resistance. Microbiol Spectr. 2016;4:481\u2013511.","journal-title":"Microbiol Spectr"},{"key":"954_CR8","doi-asserted-by":"publisher","first-page":"100887","DOI":"10.37349\/eds.2025.100887","volume":"3","author":"AM Rajesh","year":"2025","unstructured":"Rajesh AM, Pawar SS, Doriya K, Dandela R. Combating antibiotic resistance: mechanisms, challenges, and innovative approaches in antibacterial drug development. Explorat Drug Sci. 2025;3:100887.","journal-title":"Explorat Drug Sci"},{"key":"954_CR9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1039\/c2np20070h","volume":"29","author":"MO Maksimov","year":"2012","unstructured":"Maksimov MO, Pan SJ, James Link A. Lasso peptides: structure, function, biosynthesis, and engineering. Nat Prod Rep. 2012;29:996\u20131006.","journal-title":"Nat Prod Rep"},{"key":"954_CR10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41586-025-08723-7","volume":"640","author":"M Jangra","year":"2025","unstructured":"Jangra M, Travin DY, Aleksandrova EV, Kaur M, Darwish L, Koteva K, et al. A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome. Nature. 2025;640:1022\u201330.","journal-title":"Nature"},{"key":"954_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/d41573-024-00040-4","volume":"23","author":"K Kingwell","year":"2024","unstructured":"Kingwell K. Ribosome-targeted antibiotic tackles antimicrobial resistance. Nat Rev Drug Discov. 2024;23:249.","journal-title":"Nat Rev Drug Discov"},{"key":"954_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1039\/C2NP20085F","volume":"30","author":"PG Arnison","year":"2013","unstructured":"Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep. 2013;30:108\u201360.","journal-title":"Nat Prod Rep"},{"key":"954_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300472","volume":"10","author":"JT Mhlongo","year":"2023","unstructured":"Mhlongo JT, Waddad AY, Albericio F, de la Torre BG. Antimicrobial Peptide Synergies for Fighting Infectious Diseases. Adv Sci. 2023;10:e2300472.","journal-title":"Adv Sci"},{"key":"954_CR14","doi-asserted-by":"publisher","first-page":"11691","DOI":"10.3390\/ijms222111691","volume":"22","author":"A Bin Hafeez","year":"2021","unstructured":"Bin Hafeez A, Jiang X, Bergen PJ, Zhu Y. Antimicrobial Peptides: An Update on Classifications and Databases. Int J Mol Sci. 2021;22:11691.","journal-title":"Int J Mol Sci"},{"key":"954_CR15","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1021\/acs.accounts.5b00156","volume":"48","author":"JD Hegemann","year":"2015","unstructured":"Hegemann JD, Zimmermann M, Xie X, Marahiel MA. Lasso peptides: an intriguing class of bacterial natural products. Acc Chem Res. 2015;48:1909\u201319.","journal-title":"Acc Chem Res"},{"key":"954_CR16","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1021\/acs.chemrev.4c00989","volume":"125","author":"L Lombardi","year":"2025","unstructured":"Lombardi L, Genio VD, Albericio F, Williams DR. Advances in Peptidomimetics for Next-Generation Therapeutics: Strategies, Modifications, and Applications. Chem Rev. 2025;125:7099\u2013166.","journal-title":"Chem Rev"},{"key":"954_CR17","doi-asserted-by":"publisher","first-page":"14722","DOI":"10.1021\/acs.chemrev.2c00210","volume":"122","author":"C Ongpipattanakul","year":"2022","unstructured":"Ongpipattanakul C, Desormeaux EK, DiCaprio A, van der Donk WA, Mitchell DA, Nair SK. Mechanism of Action of Ribosomally Synthesized and Post-Translationally Modified Peptides. Chem Rev. 2022;122:14722\u2013814.","journal-title":"Chem Rev"},{"key":"954_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41579-024-01045-x","volume":"22","author":"I Sugrue","year":"2024","unstructured":"Sugrue I, Ross RP, Hill C. Bacteriocin diversity, function, discovery and application as antimicrobials. Nat Rev Microbiol. 2024;22:556\u201371.","journal-title":"Nat Rev Microbiol"},{"key":"954_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nchembio.2319","volume":"13","author":"JI Tietz","year":"2017","unstructured":"Tietz JI, Schwalen CJ, Patel PS, Maxson T, Blair PM, Tai HC, et al. A new genome-mining tool redefines the lasso peptide biosynthetic landscape. Nat Chem Biol. 2017;13:470\u20138.","journal-title":"Nat Chem Biol"},{"key":"954_CR20","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1021\/jacs.3c10126","volume":"146","author":"GCA da Hora","year":"2024","unstructured":"da Hora GCA, Oh M, Mifflin MC, Digal L, Roberts AG, Swanson J. Lasso Peptides: Exploring the Folding Landscape of Nature\u2019s Smallest Interlocked Motifs. J Am Chem Soc. 2024;146:4444\u201354.","journal-title":"J Am Chem Soc"},{"key":"954_CR21","doi-asserted-by":"publisher","first-page":"31435","DOI":"10.1021\/acsnano.4c11443","volume":"18","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang J, Wei K, Zhou D, Wang Z, Zeng Z, et al. Multi-Lasso Peptide-Based Synergistic Nanocomposite: A High-Stability, Broad-Spectrum Antimicrobial Agent with Potential for Combined Antibacterial Therapy. ACS Nano. 2024;18:31435\u201350.","journal-title":"ACS Nano"},{"key":"954_CR22","doi-asserted-by":"crossref","unstructured":"Kaur G, Trivedi P. Strategic defenders: Antimicrobial peptides and their impact on the innate immunity. Evolution of Antimicrobial Peptides: From Self-Defense to Therapeutic Applications 2024, pp 221\u201373.","DOI":"10.1007\/978-3-031-67515-7_9"},{"key":"954_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/14787210.2024.2377677","volume":"22","author":"X Li","year":"2024","unstructured":"Li X, Wang X, Du J, Bu X, Peng C, Duan X, et al. Applications of beta-defensins against infectious pathogenic microorganisms. Expert Rev Anti Infect Ther. 2024;22:501\u201310.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"954_CR24","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.engmic.2023.100096","volume":"3","author":"Q Ji","year":"2023","unstructured":"Ji Q, Zhou B, Shen T, Jiang T, Cheng C, He B. The lasso structure, biosynthesis, bioactivities and potential applications of Microcin J25: A novel antibacterial agent with unique mechanisms. Eng Microbiol. 2023;3:100096.","journal-title":"Eng Microbiol"},{"key":"954_CR25","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/AAC.00594-16","volume":"60","author":"CU Chukwudi","year":"2016","unstructured":"Chukwudi CU. rRNA Binding Sites and the Molecular Mechanism of Action of the Tetracyclines. Antimicrob Agents Chemother. 2016;60:4433\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"954_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-023-06780-4","volume":"625","author":"N Milicevic","year":"2024","unstructured":"Milicevic N, Jenner L, Myasnikov A, Yusupov M, Yusupova G. mRNA reading frame maintenance during eukaryotic ribosome translocation. Nature. 2024;625:393\u2013400.","journal-title":"Nature"},{"key":"954_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1021\/acsinfecdis.2c00446","volume":"9","author":"DV Carson","year":"2023","unstructured":"Carson DV, Pati\u00f1o M, Elashal HE, Cartagena AJ, Zhang Y, Whitley ME, et al. Cloacaenodin, an Antimicrobial Lasso Peptide with Activity against Enterobacter. ACS Infect Dis. 2023;9:111\u201321.","journal-title":"ACS Infect Dis"},{"key":"954_CR28","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/cbic.202100132","volume":"22","author":"LM Stariha","year":"2021","unstructured":"Stariha LM, McCafferty DG. Discovery of the Class I Antimicrobial Lasso Peptide Arcumycin. Chembiochem. 2021;22:2632\u201340.","journal-title":"Chembiochem"},{"key":"954_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-024-01701-8","volume":"14","author":"MA Eltokhy","year":"2024","unstructured":"Eltokhy MA, Saad BT, Eltayeb WN, Alshahrani MY, Radwan S, Aboshanab KM, et al. Metagenomic nanopore sequencing for exploring the nature of antimicrobial metabolites of Bacillus haynesii. AMB Express. 2024;14:52.","journal-title":"AMB Express"},{"key":"954_CR30","doi-asserted-by":"publisher","first-page":"e202400586","DOI":"10.1002\/cbic.202400586","volume":"25","author":"C Pulliam","year":"2024","unstructured":"Pulliam C, Xue D, Campbell A, Older E, Li J. Discovery and Heterologous Expression of Trilenodin, an Antimicrobial Lasso Peptide with a Unique Tri-Isoleucine Motif. Chembiochem. 2024;25:e202400586.","journal-title":"Chembiochem"},{"key":"954_CR31","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/acscatal.5c08590","volume":"16","author":"M Shi","year":"2026","unstructured":"Shi M, Duan Y, Hou SY, Xie L, Sun W, Feng L, et al. Functional and Mechanistic Investigation of a Distinct DUF6895 Family Epimerase Involved in Lasso Peptide Modification. ACS Catal. 2026;16:1757\u201372.","journal-title":"ACS Catal"},{"key":"954_CR32","doi-asserted-by":"crossref","unstructured":"Klebe G. Biologicals: Peptides, Proteins, Nucleotides, and Macrolides as Drugs, in Drug Design: From Structure and Mode-of-Action to Rational Design Concepts. 2025, Springer. p. 625-53.","DOI":"10.1007\/978-3-662-68998-1_32"},{"key":"954_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.108163","volume":"210","author":"M Suruchi","year":"2025","unstructured":"Suruchi M, Tiwari M, Pal D, Gupta AK, Jain SK. Breaking barriers in antimicrobial therapy: resistance mechanisms and novel antimicrobial strategies. Microb Pathogenes. 2025;210:108163.","journal-title":"Microb Pathogenes"},{"key":"954_CR34","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1021\/acs.accounts.1c00221","volume":"54","author":"MR Nelli","year":"2021","unstructured":"Nelli MR, Heitmeier KN, Looper RE. Dissecting the Nucleoside Antibiotics as Universal Translation Inhibitors. Acc Chem Res. 2021;54:2798\u2013811.","journal-title":"Acc Chem Res"},{"key":"954_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63278-5","volume":"16","author":"D Dey","year":"2025","unstructured":"Dey D, Mattingly JM, Zelinskaya N, Dunham CM, Conn GL. Basis for selective drug evasion of an aminoglycoside-resistance ribosomal RNA modification. Nat Commun. 2025;16:7992.","journal-title":"Nat Commun"},{"key":"954_CR36","doi-asserted-by":"publisher","first-page":"8184","DOI":"10.3390\/ijms26178184","volume":"26","author":"P Mucha","year":"2025","unstructured":"Mucha P, Ruczy\u0144ski J, Prochera K, Rekowski P. Lasso Peptides-A New Weapon Against Superbugs. Int J Mol Sci. 2025;26:8184.","journal-title":"Int J Mol Sci"},{"key":"954_CR37","doi-asserted-by":"publisher","first-page":"e202513115","DOI":"10.1002\/anie.202513115","volume":"64","author":"PL Wang","year":"2025","unstructured":"Wang PL, Chen P, Yang R, Tetlow DJ, Zhang ZH, Han J, et al. Crown Ether-Peptide Rotaxanes. Angew Chem Int Ed Engl. 2025;64:e202513115.","journal-title":"Angew Chem Int Ed Engl"},{"key":"954_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/antibiotics13010094","volume":"13","author":"T Maeda","year":"2024","unstructured":"Maeda T, Furusawa C. Laboratory Evolution of Antimicrobial Resistance in Bacteria to Develop Rational Treatment Strategies. Antibiotics. 2024;13:94.","journal-title":"Antibiotics"},{"key":"954_CR39","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1126\/science.aag0822","volume":"353","author":"M Baym","year":"2016","unstructured":"Baym M, Lieberman TD, Kelsic ED, Chait R, Gross R, Yelin I, et al. Spatiotemporal microbial evolution on antibiotic landscapes. Science. 2016;353:1147\u201351.","journal-title":"Science"},{"key":"954_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02826-21","volume":"13","author":"A Lanois-Nouri","year":"2022","unstructured":"Lanois-Nouri A, Pantel L, Fu J, Houard J, Ogier JC, Polikanov YS, et al. The Odilorhabdin Antibiotic Biosynthetic Cluster and Acetyltransferase Self-Resistance Locus Are Niche and Species Specific. mBio. 2022;13:e0282621.","journal-title":"mBio"},{"key":"954_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04206-23","volume":"12","author":"RR Nair","year":"2024","unstructured":"Nair RR, Andersson DI, Warsi OM. Antibiotic resistance begets more resistance: chromosomal resistance mutations mitigate fitness costs conferred by multi-resistant clinical plasmids. Microbiol Spectr. 2024;12:e0420623.","journal-title":"Microbiol Spectr"},{"key":"954_CR42","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1128\/AAC.00131-06","volume":"50","author":"KS Long","year":"2006","unstructured":"Long KS, Poehlsgaard J, Kehrenberg C, Schwarz S, Vester B. The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics. Antimicrob Agents Chemother. 2006;50:2500\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"954_CR43","doi-asserted-by":"publisher","first-page":"gkaf046","DOI":"10.1093\/nar\/gkaf046","volume":"53","author":"B Bibel","year":"2025","unstructured":"Bibel B, Raskar T, Couvillion M, Lee M, Kleinman JI, Takeuchi-Tomita N, et al. Context-specific inhibition of mitochondrial ribosomes by phenicol and oxazolidinone antibiotics. Nucleic Acids Res. 2025;53:gkaf046.","journal-title":"Nucleic Acids Res"},{"key":"954_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00161-23","volume":"3","author":"Y Yang","year":"2024","unstructured":"Yang Y, Xie S, He F, Xu Y, Wang Z, Ihsan A, et al. Recent development and fighting strategies for lincosamide antibiotic resistance. Clin Microbiol Rev. 2024;3:e0016123.","journal-title":"Clin Microbiol Rev"},{"key":"954_CR45","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1021\/acsinfecdis.5c00885","volume":"12","author":"M Jangra","year":"2026","unstructured":"Jangra M, Travin DY, Kaur M, Hackenberger D, Koteva K, Polikanov YS, et al. An Acetyltransferase Conferring Self-Resistance of the Producer to Lasso Peptide Antibiotic Lariocidin. ACS Infect Dis. 2026;12:714\u201323.","journal-title":"ACS Infect Dis"},{"key":"954_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11274-024-04106-8","volume":"40","author":"S Sun","year":"2024","unstructured":"Sun S, Chen X. Mechanism-guided strategies for combating antibiotic resistance. World J Microbiol Biotechnol. 2024;40:295.","journal-title":"World J Microbiol Biotechnol"},{"key":"954_CR47","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01483-24","volume":"69","author":"ME Petersen","year":"2025","unstructured":"Petersen ME, Khamas AB, \u00d8stergaard LJ, J\u00f8rgensen NP, Meyer RL. Combination therapy delays antimicrobial resistance after adaptive laboratory evolution of Staphylococcus aureus. Antimicrob Agents Chemother. 2025;69:e0148324.","journal-title":"Antimicrob Agents Chemother"},{"key":"954_CR48","doi-asserted-by":"publisher","first-page":"14966","DOI":"10.3390\/ijms241914966","volume":"24","author":"K Browne","year":"2023","unstructured":"Browne K, Kuppusamy R, Walsh WR, Black DS, Willcox M, Kumar N, et al. Antimicrobial Peptidomimetics Prevent the Development of Resistance against Gentamicin and Ciprofloxacin in Staphylococcus and Pseudomonas Bacteria. Int J Mol Sci. 2023;24:14966.","journal-title":"Int J Mol Sci"},{"key":"954_CR49","doi-asserted-by":"publisher","first-page":"1625300","DOI":"10.3389\/fmicb.2025.1625300","volume":"16","author":"DM Ramirez","year":"2025","unstructured":"Ramirez DM, Schweizer F. Development of polymyxin-and aminoglycoside-based outer membrane permeabilizers: A review. Front Microbiol. 2025;16:1625300.","journal-title":"Front Microbiol"},{"key":"954_CR50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/microorganisms11020259","volume":"11","author":"P Nikolic","year":"2023","unstructured":"Nikolic P, Mudgil P. The Cell Wall, Cell Membrane and Virulence Factors of Staphylococcus aureus and Their Role in Antibiotic Resistance. Microorganisms. 2023;11:259.","journal-title":"Microorganisms"},{"key":"954_CR51","doi-asserted-by":"publisher","first-page":"e2113632118","DOI":"10.1073\/pnas.2113632118","volume":"118","author":"G K\u00f6nig","year":"2021","unstructured":"K\u00f6nig G, Sokkar P, Pryk N, Heinrich S, M\u00f6ller D, Cimicata G, et al. Rational prioritization strategy allows the design of macrolide derivatives that overcome antibiotic resistance. Proc Natl Acad Sci USA. 2021;118:e2113632118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"954_CR52","doi-asserted-by":"publisher","first-page":"115040","DOI":"10.1016\/j.ejmech.2022.115040","volume":"247","author":"EME Dokla","year":"2023","unstructured":"Dokla EME, Abutaleb NS, Milik SN, Kandil E, Qassem OM, Elgammal Y, et al. SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria. Eur J Med Chem. 2023;247:115040.","journal-title":"Eur J Med Chem"},{"key":"954_CR53","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.3390\/microorganisms13122796","volume":"13","author":"P Hindieh","year":"2025","unstructured":"Hindieh P, Yaghi J, Assaf JC, Chokr A, Atoui A, Tzenios N, et al. Emerging Multimodal Strategies for Bacterial Biofilm Eradication: A Comprehensive Review. Microorganisms. 2025;13:2796.","journal-title":"Microorganisms"},{"key":"954_CR54","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/pro.3589","volume":"28","author":"R Ero","year":"2019","unstructured":"Ero R, Kumar V, Su W, Gao YG. Ribosome protection by ABC-F proteins-Molecular mechanism and potential drug design. Protein Sci. 2019;28:684\u201393.","journal-title":"Protein Sci"},{"key":"954_CR55","doi-asserted-by":"publisher","first-page":"1719798","DOI":"10.3389\/fmicb.2025.1719798","volume":"16","author":"M Sartori","year":"2025","unstructured":"Sartori M, Toppo S, Lavezzo E. Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. Front Microbiol. 2025;16:1719798.","journal-title":"Front Microbiol"},{"key":"954_CR56","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.procbio.2024.07.002","volume":"145","author":"D Chettri","year":"2024","unstructured":"Chettri D, Rani A, Sharma B, Selvaraj M, Assiri MA, Verma AK. Antimicrobial peptides: source, application and recent developments. Process Biochem. 2024;145:288\u2013301.","journal-title":"Process Biochem"},{"key":"954_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06321-9","volume":"23","author":"S Zheng","year":"2025","unstructured":"Zheng S, Tu Y, Li B, Qu G, Li A, Peng X, et al. Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges. J Transl Med. 2025;23:292.","journal-title":"J Transl Med"},{"key":"954_CR58","doi-asserted-by":"publisher","first-page":"1779022","DOI":"10.3389\/fmicb.2026.1779022","volume":"17","author":"VU Chigozie","year":"2026","unstructured":"Chigozie VU, Esimone CO. Bacterial secondary metabolites as resistance-modifying adjuvants: microbial origins, molecular mechanisms, and translational relevance. Front Microbiol. 2026;17:1779022.","journal-title":"Front Microbiol"},{"key":"954_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60544-4","volume":"16","author":"X Ouyang","year":"2025","unstructured":"Ouyang X, Ran X, Xu H, Al-Abssi R, Zhao YL, Link AJ, et al. LassoPred: a tool to predict the 3D structure of lasso peptides. Nat Commun. 2025;16:5497.","journal-title":"Nat Commun"},{"key":"954_CR60","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1039\/D0NP00027B","volume":"38","author":"M Montalb\u00e1n-L\u00f3pez","year":"2021","unstructured":"Montalb\u00e1n-L\u00f3pez M, Scott TA, Ramesh S, Rahman IR, van Heel AJ, Viel JH, et al. New developments in RiPP discovery, enzymology and engineering. Nat Prod Rep. 2021;38:130\u2013239.","journal-title":"Nat Prod Rep"},{"key":"954_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63412-3","volume":"16","author":"X Mi","year":"2025","unstructured":"Mi X, Barrett SE, Mitchell DA, Shukla D. LassoESM a tailored language model for enhanced lasso peptide property prediction. Nat Commun. 2025;16:8545.","journal-title":"Nat Commun"},{"key":"954_CR62","doi-asserted-by":"publisher","first-page":"12375","DOI":"10.1021\/acs.chemrev.9b00402","volume":"119","author":"SJ de Veer","year":"2019","unstructured":"de Veer SJ, Kan MW, Craik DJ. Cyclotides: From Structure to Function. Chem Rev. 2019;119:12375\u2013421.","journal-title":"Chem Rev"},{"key":"954_CR63","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1073\/pnas.1817352116","volume":"116","author":"NR Braffman","year":"2019","unstructured":"Braffman NR, Piscotta FJ, Hauver J, Campbell EA, Link AJ, Darst SA. Structural mechanism of transcription inhibition by lasso peptides microcin J25 and capistruin. Proc Natl Acad Sci USA. 2019;116:1273\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"954_CR64","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02752-21","volume":"10","author":"S Telhig","year":"2022","unstructured":"Telhig S, Ben Said L, Torres C, Rebuffat S, Zirah S, Fliss I. Evaluating the Potential and Synergetic Effects of Microcins against Multidrug-Resistant Enterobacteriaceae. Microbiol Spectr. 2022;10:e0275221.","journal-title":"Microbiol Spectr"},{"key":"954_CR65","doi-asserted-by":"publisher","first-page":"e202200075","DOI":"10.1002\/cmdc.202200075","volume":"17","author":"PH Chen","year":"2022","unstructured":"Chen PH, Sung LK, Hegemann JD, Chu J. Disrupting Transcription and Folate Biosynthesis Leads to Synergistic Suppression of Escherichia coli Growth. ChemMedChem. 2022;17:e202200075.","journal-title":"ChemMedChem"},{"key":"954_CR66","doi-asserted-by":"publisher","first-page":"111922","DOI":"10.1016\/j.isci.2025.111922","volume":"28","author":"A Boudrioua","year":"2025","unstructured":"Boudrioua A, Ba\u00ebtz B, Desmadril S, Goulard C, Groo AC, Lombard C, et al. Lasso peptides sviceucin and siamycin I exhibit anti-virulence activity and restore vancomycin effectiveness in vancomycin-resistant pathogens. iScience. 2025;28:111922.","journal-title":"iScience"},{"key":"954_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molcel.2018.03.001","volume":"70","author":"L Pantel","year":"2018","unstructured":"Pantel L, Florin T, Dobosz-Bartoszek M, Racine E, Sarciaux M, Serri M, et al. Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal Site. Mol Cell. 2018;70:83\u201394.e7.","journal-title":"Mol Cell"},{"key":"954_CR68","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/35030019","volume":"407","author":"AP Carter","year":"2000","unstructured":"Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature. 2000;407:340\u20138.","journal-title":"Nature"},{"key":"954_CR69","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1073\/pnas.1216691110","volume":"110","author":"L Jenner","year":"2013","unstructured":"Jenner L, Starosta AL, Terry DS, Mikolajka A, Filonava L, Yusupov M, et al. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis. Proc Natl Acad Sci USA. 2013;110:3812\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"954_CR70","doi-asserted-by":"publisher","unstructured":"Zhao M et al. In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model. Antimicrob Agents Chemother, 2018. 62. https:\/\/doi.org\/10.1128\/aac.01067-18.","DOI":"10.1128\/aac.01067-18"},{"key":"954_CR71","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/nar\/gkw018","volume":"44","author":"MG Gagnon","year":"2016","unstructured":"Gagnon MG, Roy RN, Lomakin IB, Florin T, Mankin AS, Steitz TA. Structures of proline-rich peptides bound to the ribosome reveal a common mechanism of protein synthesis inhibition. Nucleic Acids Res. 2016;44:2439\u201350.","journal-title":"Nucleic Acids Res"},{"key":"954_CR72","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","volume":"156","author":"S Menon","year":"2014","unstructured":"Menon S, Dibble CC, Talbott G, Hoxhaj G, Valvezan AJ, Takahashi H, et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell. 2014;156:771\u201385.","journal-title":"Cell"},{"key":"954_CR73","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol. 2005;3:238\u201350.","journal-title":"Nat Rev Microbiol"},{"key":"954_CR74","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.193.9.1067","volume":"193","author":"A Peschel","year":"2001","unstructured":"Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med. 2001;193:1067\u201376.","journal-title":"J Exp Med"},{"key":"954_CR75","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1021\/acschembio.4c00009","volume":"19","author":"DV Carson","year":"2024","unstructured":"Carson DV, Juarez RJ, Do T, Yang ZJ, Link AJ. Antimicrobial Lasso Peptide Cloacaenodin Utilizes a Unique TonB-Dependent Transporter to Access Susceptible Bacteria. ACS Chem Biol. 2024;19:981\u201391.","journal-title":"ACS Chem Biol"},{"key":"954_CR76","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1021\/acschembio.2c00276","volume":"17","author":"GV de Castro","year":"2022","unstructured":"de Castro GV, Worm DJ, Grabe GJ, Rowan FC, Haggerty L, de la Lastra AL, et al. Characterization of the Key Determinants of Phd Antitoxin Mediated Doc Toxin Inactivation in Salmonella. ACS Chem Biol. 2022;17:1598\u2013606.","journal-title":"ACS Chem Biol"},{"key":"954_CR77","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1021\/acschembio.2c00420","volume":"17","author":"T Do","year":"2022","unstructured":"Do T, Thokkadam A, Leach R, Link AJ. Phenotype-Guided Comparative Genomics Identifies the Complete Transport Pathway of the Antimicrobial Lasso Peptide Ubonodin in Burkholderia. ACS Chem Biol. 2022;17:2332\u201343.","journal-title":"ACS Chem Biol"},{"key":"954_CR78","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nbt.3043","volume":"32","author":"D Bikard","year":"2014","unstructured":"Bikard D, Euler CW, Jiang W, Nussenzweig PM, Goldberg GW, Duportet X, et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol. 2014;32:1146\u201350.","journal-title":"Nat Biotechnol"},{"key":"954_CR79","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"YY Liu","year":"2016","unstructured":"Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16:161\u20138.","journal-title":"Lancet Infect Dis"},{"key":"954_CR80","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"BT Tsuji","year":"2019","unstructured":"Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL, Forrest A, et al. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019;39:10\u201339.","journal-title":"Pharmacotherapy"},{"key":"954_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","volume":"19","author":"P Jault","year":"2019","unstructured":"Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial. Lancet Infect Dis. 2019;19:35\u201345.","journal-title":"Lancet Infect Dis"},{"key":"954_CR82","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","volume":"25","author":"KE Kortright","year":"2019","unstructured":"Kortright KE, Chan BK, Koff JL, Turner PE. Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. Cell Host Microbe. 2019;25:219\u201332.","journal-title":"Cell Host Microbe"},{"key":"954_CR83","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nbt.3011","volume":"32","author":"RJ Citorik","year":"2014","unstructured":"Citorik RJ, Mimee M, Lu TK. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol. 2014;32:1141\u20135.","journal-title":"Nat Biotechnol"},{"key":"954_CR84","doi-asserted-by":"publisher","first-page":"e1006990","DOI":"10.1371\/journal.ppat.1006990","volume":"14","author":"E Pursey","year":"2018","unstructured":"Pursey E, S\u00fcnderhauf D, Gaze WH, Westra ER, van Houte S. CRISPR-Cas antimicrobials: Challenges and future prospects. PLoS Pathog. 2018;14:e1006990.","journal-title":"PLoS Pathog"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00954-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:09:19Z","timestamp":1787573359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00954-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":84,"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1038\/s41429-026-00954-8","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"During the preparation of this work, the authors used AI-assisted tools only for language refinement, organization of manuscript sections, and improvement of readability. After using these tools, the authors reviewed, verified, edited, and approved the content and take full responsibility for the accuracy and integrity of the final manuscript.","order":2,"name":"Ethics","label":"Declaration of Generative AI and AI-Assisted Technologies in the Manuscript Preparation Process","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}